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ABSTRACT 
Objectives: The aim of this study was to assess pharmacists’ and student pharmacists’ understanding of drug-induced adverse events 
(DIAEs) and prescribing cascades (PC) and assess their willingness to use system-level approaches to identify DIAEs and PC for future 
patient interventions.  
Methods: Following a continuing education presentation on DIAEs and PC, pharmacists and student pharmacists completed a survey. 
A retrospective post-then-pre method was used to assess knowledge. McNemar tests and chi-square analyses were used to determine 
differences in understanding of DIAEs and PCs, as well as between pharmacists and student pharmacists.  
Results: A total of 53 participants completed the survey including pharmacists (n=39) and student pharmacists (n=14). Fewer 
participants had previously heard of the term (40%; p<0.001) and concept (60%; p<0.001) of PC compared to the term and concept 
(98% in both) of DIAE. Student pharmacists were less likely to have heard of the term PC (14%) compared to pharmacists (40%; 
p=0.029). There was no difference in knowledge of the concept of PC. Nearly all respondents were willing to assess for DIAE and PC in 
their patients, and over 75% of respondents were willing to receive systems-based alerts for DIAE and PC. 
Conclusion: There was a differential in understanding DIAE and PC among respondents. Programs aimed at building understanding, as 
well as systems-level alerts for PC, are needed.   
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BACKGROUND 
Older adults are major consumers of prescription and non-
prescription medications. Two-thirds of community-dwelling 
older adults (>65 years old) take five or more prescriptions, 
over-the-counter (OTC) products, and dietary supplements.1 
Additionally, 36% of older adults take five or more prescription 
medications. Institutionalized older adults consume greater 
numbers of medications, as approximately 50% of older adults 
in the long-term care setting take nine or more medications.2 
Taking multiple or inappropriate medications may predispose 
patients to drug-induced adverse events (DIAEs), along with 
changes in pharmacokinetics and pharmacodynamics 
associated with aging, being female, and having genetic 
factors, sustaining multiple co-existing medical problems, and 
having cognitive issues.3   
 
DIAEs are unwanted, potentially harmful outcomes related to 
the utilization of a medication that may be idiopathic or 
related to its mechanism of action that typically require a dose 
reduction or treatment discontinuation.4-6  The degree  
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of the DIAE’s severity may vary between patients and amongst 
different medications ranging from mild discomfort to 
hospitalization and death.5 An unintended consequence of a 
DIAE is a prescribing cascade (PC). PC occurs when a DIAE is 
misinterpreted as a new medical condition, resulting in the 
prescription of a new, potentially unnecessary medication.7  
 
Previous studies have identified DIAEs resulting in PC.8-13 Yet 
there is no published information on any member of the 
healthcare team’s knowledge of PC and how this knowledge 
can be used clinically. In particular, pharmacists’ and student 
pharmacists’ understanding of DIAEs and PC or their 
willingness to participate in interventions to mitigate DIAEs 
and PC is unclear. More information is needed on pharmacists’ 
knowledge, as it may change a pharmacist’s approach to 
medication review to include evaluating for PC. The aim of this 
study was to assess pharmacists’ and student pharmacists’ 
understanding of DIAEs and PC and assess their willingness to 
use patient- and system-levels approaches to identify DIAEs 
and PC for future patient interventions.  
 
METHODS 
Measures 
A 150-minute continuing education presentation over two 
sessions entitled “Drug-Induced Adverse Events and 
Prescribing Cascades in the Elderly” was delivered on July 18th, 
2015 to pharmacists and student pharmacists attending the 
American Society of Consultant Pharmacists Midwest Regional 
Conference. The objectives of this presentation were to:            
1) differentiate between DIAEs and PC in the elderly,                      
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2) evaluate   the primary literature regarding DIAEs and PC in 
the elderly, 3) identify and intervene on DIAEs and PC in the 
elderly given a patient case, and 4) create one’s own PC case. 
 
Following the presentation, participants were given ten 
minutes to complete a voluntary paper survey (available upon 
request) regarding the content. A retrospective post-then-pre 
method was used, which allows for participants to better 
assess their knowledge following the presentation.14 As 
opposed to a pre-test post-test method, the post-then-pre 
method allows participants to assess a question with the same 
point of reference.14 An issue with the pre-test post-test 
method is that the post-test may indicate there is a reduced 
knowledge of the educational outcome relative to baseline 
knowledge due to an overestimation of prior knowledge, thus 
resulting in an underestimation of true knowledge.  The survey 
was reviewed by three colleagues with expertise in survey 
design for content validity. Alterations were made; however, 
no pilot testing was conducted.  This study was approved by 
the St. Louis College of Pharmacy Institutional Review Board. 
Variables 
 
For comparison purposes, the answers to ‘Yes’ and ‘No or Did 
Not Answer’ questions were transformed to ‘Yes’ and ‘No’, 
respectively. The answers to ‘Agree or Strongly Agree’ and 
‘Neutral, Disagree, Strongly Disagree, or Did Not Answer’ 
questions were transformed to ‘Agree’ and ‘Disagree’, 
respectively. The answers to ‘Slightly Willing or Very Willing’ 
and ‘Neutral, Slightly Not Willing, Not Willing, or Did Not 
Answer’ questions were transformed to ‘Willing’ and ‘Not 
Willing’, respectively. 
Statistical Analyses 
 
Descriptive statistics were used to describe characteristics and 
responses in three categories: all respondents, pharmacists 
only, and student pharmacists only. Next, questions on DIAEs 
were compared to questions on PC to determine if there were 
differences in understanding and identification, using the 
McNemar Test among all respondents, pharmacists, and 
student pharmacists. Chi-square analysis (or Fisher’s Exact 
Test, when appropriate) were used to compare pharmacists’ 
to student pharmacists’ responses. All data were considered 
two-sided with an a priori level of significance of 0.05. All 
statistical analyses were performed using IBM-SPSS, version 
22.0 (IBM Corp., Armonk, NY).  
 
RESULTS 
A total of 53 participants completed the survey, including 39 
pharmacists and 14 student pharmacists. A majority of 
respondents were female, 80% of pharmacists had at least 15 
years of practice experience, and approximately 50% of 
pharmacists practiced in the long-term care setting (Table 1).  
Table 2 compares knowledge of DIAE versus PC among all 
respondents, pharmacists, and student pharmacists. Overall, 
greater than 95% of respondents had previously heard of the 
term and concept of DIAE, while significantly fewer 
respondents had previously heard the term (40%, p<0.001) 
and concept (60%, p<0.001) of PC (Table 2). A higher 
proportion of all respondents had previously identified DIAEs 
in patients compared to PC (p<0.001).  
Table 3 assesses differences in knowledge between 
pharmacists and student pharmacists regarding DIAE and PC. 
Student pharmacists were also significantly less likely to have 
previously heard of the term PC compared to pharmacists 
(p=0.029), but there was no difference in previously being 
aware of the concept of PC (p=0.773). Pharmacists identified 
more DIAEs (p<0.001) and PC (p=0.004) in practice compared 
to student pharmacists. 
Ninety-eight percent (n=52) of respondents were likely to look 
for DIAEs and PC in their future patient interventions. 
Additionally, 88.7% and 77.4% of respondents were willing to 
receive systems-based notifications to confirm both DIAEs and 
PC, respectively, in their future patient interventions. When 
asked about their preference for identifying DIAEs and PC on 
their own versus a systems-based approach, 53% (n=28) and 
49% (n=26) of all respondents had no preference for either 
method of identifying DIAE and PC, respectively.  
Over 90% of respondents recommended that this topic be 
presented to their colleagues in pharmacy and healthcare. 
Moreover, approximately 90% of respondents would read 
future publications and incorporate publications into practice 
regarding DIAE and PC. Three-quarters of respondents 
recommended that this topic be discussed with older adult 
patients.  
DISCUSSION 
To the authors’ knowledge, this is the first study to identify 
pharmacists’ and student pharmacists’ knowledge of DIAEs 
and PC and their willingness to identify DIAEs and PC in future 
patient interventions.  Nearly all respondents had previously 
heard of the term and concept of DIAE with no difference 
between pharmacists and student pharmacists. However, 
pharmacists were less likely to be aware of PC compared to 
DIAE, as less than 50% had previously heard of the term and 
approximately 60% had previously heard of the concept of PC. 
In general, this may be an overestimation as these pharmacists 
were attending a geriatric pharmacy conference; therefore, 
many respondents work with the geriatric population and are 
more likely to encounter patients with a PC. Only 15% of 
student pharmacists had previously heard of the term PC, 
while 57% were aware of the concept. The Geriatric 
Curriculum Guide, 3rd Edition suggests incorporating adverse 
events into the geriatric curricula; however, it does not 
specifically include PC.15 At least one school of pharmacy, the 
University of Charleston School of Pharmacy, incorporates PC 
into its curricula.16 ‘The Prescribing Cascade Game’ introduces 
the concept, term, and examples of PC to student pharmacists 
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in the second year of their professional program. This learning 
activity can be emulated by other schools of pharmacy as a 
method of introducing student pharmacists to PC. However, it 
is currently unclear the proportion of pharmacy school 
curricula covering PC within geriatric modules. 
Based on this survey, both pharmacist and student pharmacist 
respondents will actively and passively investigate DIAEs and 
PC in future patient interventions. There are few studies that 
have confirmed PC using pharmacoepidemiological techniques 
that can be used by pharmacists to justify interventions.8-13 
Approximately 90% of respondents in our study were willing to 
read and incorporate future studies on DIAEs and PC in future 
patient interventions. Therefore, this may be an area of 
educational need and potential for expanded observational 
and interventional research.  
Currently, there are no interventional studies that aim to 
reduce PC; however, several studies have used systems-based 
approaches to identify adverse events.17 Pharmacists play a 
vital role as the “safety-net” for healthcare providers in 
medication utilization and are essential to the identification of 
PC in a variety of practice settings.18 Based on our study, 
approximately 75% of participating pharmacists were willing 
to receive systems-based alerts so that DIAEs and PC can be 
confirmed and intervened. Pharmacists’ willingness to engage 
in these interventions can further justify performing            
future quasi-experimental or experimental research on 
interventional techniques. For example, a systems-based 
approach can identify a PC (e.g., lisinopril and a new order for 
cough medication) and alert the pharmacist to differentiate 
between an angiotensin-converting enzyme inhibitor (ACE 
inhibitor)-induced cough and cough secondary to an 
infection.19 The pharmacist is in an ideal situation to 
communicate with the patient and/or physician or review a 
medical record to confirm the PC and suggest changes in 
therapy. This action can reduce medication burden and costs 
for patients, improve quality of life, and mitigate downstream 
consequences of PC.   
A recent commentary from Steinman stated that providers 
currently do not have methods to evaluate ongoing 
medications for adverse events or to determine the necessity 
of medications and called for systems to periodically assess 
benefits, harms, and ongoing needs of medications to inform 
prescribers.20 The approach of identifying DIAEs through PC 
may be one such method to provide individualized 
assessments to identify potentially unnecessary medications 
that may be contributing to adverse events.  
Limitations 
There are some limitations to this study. Using a post-then-pre 
method, there may be an unconscious desire of the 
respondent to answer survey questions in a way that the 
researchers would want him or her to respond; however, this 
approach allows respondents to more accurately answer 
questions regarding baseline knowledge. Additionally, 
information from this survey was drawn from a non-random 
sample of pharmacists and student pharmacists from the 
Midwest, who attended a regional pharmacy conference. 
These results may not be generalizable to other regions of the 
country or to pharmacists who do not attend these types of 
conferences. Multiple types of educational interventions may 
also be needed as one educational session may not be enough 
to change behavior.  
CONCLUSION 
A stakeholder survey of pharmacists and student pharmacists 
at a geriatric regional conference suggested differences in 
understanding of the terms and concepts of DIAEs and PC. 
These results identify a potential knowledge gap, specifically in 
PC, and call attention to the need for increased continuing 
education on PC and the integration of PC in pharmacy 
curricula. This survey suggests expanding research efforts in 
identifying DIAEs and PC, as pharmacist engagement is vitally 
important to the success of this type of intervention. 
Furthermore, this survey suggests a potential willingness for 
pharmacists to engage in interventions aimed to reduce DIAEs 
and PC in older adults and justifies continued expansion in this 
area of research. 
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Table 1: Participant Characteristics 
 
 All Respondents 
n (%) 
(n=53) 
Pharmacists 
n (%) 
(n=39) 
Student Pharmacists 
n (%) 
(n=14) 
Gender 
Male 
Female 
 
19 (35.8) 
34 (64.2) 
 
18 (46.2) 
21 (53.8) 
 
1 (7.1) 
13 (92.9) 
Years of Practice 
Student 
< 5 years 
5 to 15 years 
> 15 years 
 
14 (26.4) 
5 (9.4) 
3 (5.7) 
31 (58.5) 
 
-- 
5 (12.8) 
3 (7.7) 
31 (79.5) 
 
14 (100) 
-- 
-- 
-- 
Practice Setting 
Academia 
Clinical 
Community 
Hospital 
Independent Living Facility 
Long-Term Care Setting 
Student 
Did Not Answer 
 
1 (1.9) 
4 (7.5) 
4 (7.5) 
3 (5.7) 
1 (1.9) 
25 (47.2) 
14 (26.4) 
1 (1.9) 
 
1 (2.6) 
4 (10.3) 
4 (10.3) 
3 (7.7) 
1 (2.6) 
25 (64.1) 
0 (0) 
1 (2.6) 
 
-- 
-- 
-- 
-- 
-- 
-- 
14(100) 
-- 
Geographic Region of Practice 
Midwest 
South 
Did Not Answer 
 
49 (92.5) 
2 (3.8) 
2 (3.8) 
 
36 (92.3) 
2 (5.1) 
1 (2.6) 
 
13(92.9) 
0 (0) 
1(7.1) 
 
  
Student Project EDUCATION 
 
http://z.umn.edu/INNOVATIONS                           2017, Vol. 8, No. 2, Article 19                          INNOVATIONS in pharmacy   6 
 
 
Table 2: Current Understanding of Drug-Induced Adverse Events and Prescribing Cascades 
 
 DIAE – n (%) PC – n (%) P-Value* 
All Responders (n=53)        
     Prior to the Presentation, I have heard of the term: 52(98.1) 21(39.6) <0.001 
     Prior to the Presentation, I have heard of the concept of: 52(98.1) 32(60.4) <0.001 
     I have identified a ___ in a Patient? 42(79.2) 21(39.6) <0.001 
Pharmacists (n=39)  
     Prior to the Presentation, I have heard of the term: 38(97.4) 19(48.7) <0.001 
     Prior to the Presentation, I have heard of the concept of: 39(100) 24(61.5) <0.001 
     I have identified a ___ in a Patient? 36(92.3) 20(51.3) <0.001 
Student Pharmacists (n=14)  
     Prior to the Presentation, I have heard of the term: 14(100) 2(14.3) <0.001 
     Prior to the Presentation, I have heard of the concept of: 13(92.9) 8(57.1) 0.063 
     I have identified a ___ in a Patient? 6(42.9) 1(7.1) 0.063 
*=Comparison using McNemar Test 
DIAE = Drug-Induced Adverse Events; PC = Prescribing Cascades 
 
 
Table 3: Current Understanding of Drug-Induced Adverse Events and Prescribing Cascades by Experience 
 Pharmacists 
 
(n=39) – n(%) 
Student 
Pharmacists 
(n=14) – n(%) 
P-Value* 
Prior to the Presentation, I have heard of the term:  
     DIAE 38(97.4) 14(100) 1.00 
     PC 21(39.6) 2(14.3) 0.029 
Prior to the Presentation, I have heard of the concept:  
     DIAE 39(100) 13(92.9) 0.264 
     PC 24(61.5) 8(57.1) 0.773 
I have identified a ___ in a Patient?  
     DIAE 36(92.3) 6(42.9) <0.001 
     PC 20(51.3) 1(7.1) <0.001 
*=Comparison using Chi-Square Test or Fisher’s Exact Test 
DIAE = Drug-Induced Adverse Events; PC = Prescribing Cascades 
 
 
